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The potential applications of operative laparoscopy have expanded with improvements in technol-
ogy and instrumentation. With newly developed techniques to complete both pelvic and paraaottic
lymph node dissection, the use of the laparoscope has increased in patients with pelvic malignancies.
Gynecologic oncologists are currently incorporating the techniques of operative laparoscopy in the
management ofpatients with cervical, endometxial, and ovarian cancer. Multicenter prospective clin-
ical trials are necessary to further define the role of laparoscopy in gynecologic oncology.
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Historically, the laparoscope has been used for diagnos-
tic purposes and for sterilization procedures. Due to tech-
nologic advances, operative laparoscopynow plays a role
in the management of a wide variety of benign gyneco-
logical conditions including ectopic pregnancy, en-
dometriosis, pelvic pain, leiomyomata, and adnexal
masses. Similarly, the role of operative laparoscopy in
the management of malignant disease has expanded.
With newly developed techniques to complete both
pelvic and paraaortic lymph node dissection, the use of
the laparoscope has increased in patients with pelvic ma-
lignancies. Gynecologic oncologists are currently incor-
porating the techniques of operative laparoscopy in the
management of patients with cervical, endometrial, and
ovarian cancer.
The main role for operative laparoscopy inwomen with
gynecologic neoplasms is in surgical staging. The tech-
nique of laparoscopic pelvic lymph node dissection was
first described in women with cervical carcinoma by
Querleu et al. in 1991 (1). Subsequently, other investiga-
tors have reported on the safety and efficacy of this pro-
cedure in patients with cancers of the cervix,
endometrium, and ovary (2-4). Critical to the addition of
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laparoscopy to oncology was the development of tech-
niques forparaaortic lymphadenectomy. For surgical stag-
ing to be complete, access to bilateral paraaortic nodal
tissue is imperative (Fig. 1). Nezhat et al. (5) first pub-
lished acase reportofalaparoscopic radical hysterectomy
that included a low fight paraaortic nodal dissection in
1992. Others had previously begun to develop strategies
for laparoscopic paraaortic lymph node sampling in ani-
mal models (6). Currently, there are a number of series
that confirm the feasibility ofremoving bilateral paraaor-
tic lymph nodes laparoscopically (2,4,7).
The most significant experience to date with laparo-
scopic lymphadenectomy is in women with cervical car-
cinoma. Cervical carcinoma remains a clinically staged
disease as recommended by the International Federation
of Gynecology and Obstetrics (FIGO). However, clinical
staging is inadequate in estimating tumor spread. The dis-
crepancy between clinical and surgical staging ranges
from 20 to 48% depending on the clinical stage (8). The
primary benefit of surgical staging is the ability to iden-
tify patients who may benefit from extended field irradi-
ation. Although the value of surgical staging remains
controversial, management decisions based on the infor-
mation result in an improvement in survival in 2.5 to 7%
of women whose cancer is surgically staged (8,9). Other
advantages of surgical staging include the removal of
bulky lymph nodes, removal of diseased adnexae, and
ovarian transposition.186 E.M. HARTENBACH AND J. M. FOWLER
Figure I Left-sided paraaortic lymph node dissection accomplished via laparoscopy.
Laparoscopic lymphadenectomy in cervical cancer pa-
tients is utilized in two clinical settings (10). In patients
with early stage disease (FIGO IA-IIA) that is suitable for
radical hysterectomy, lymph node sampling is carried out
before radical hysterectomy. Lymph nodes are assessedby
frozen section and radical hysterectomy is performed if
they are negative for malignancy. In patients with FIGO
IB-IIA disease as many as 5 to 10% will have positive
common iliac and paraaortic lymph nodes (11). Therefore,
laparoscopic sampling can save these patients from un-
dergoing a laparotomy. If the lymph nodes are positive,
the surgical staging is completed laparoscopically, and the
patient is then treated with radiation therapy. In contrast,
patients with advanced disease (FIGO lIB-IV) are surgi-
cally staged with laparoscopic pelvic and paraaortic lym-
phadenectomy. Removal of bulky, grossly positive lymph
nodes can be carried out in the majority of these patients.
L.vmth node yield is adequate and compares with that of
staging laparotomies (3,10). Radiation can then be tailored
to disease extent. There is some concern that transperi-
toneal laparoscopic lymphadenectomy techniques may in-
crease radiation-related enteric morbidity. However,
animal studies indicate that transperitoneal laparoscopic
procedures may not produce any more surgical adhesions
than extraperitoneal procedures (12). In addition, to the
use of the laparoscope for surgical staging, there are case
reports of laparoscopic radical hysterectomy and laparo-
scopically assisted radical vaginal hysterectomy
(5,13,14). It remains to be seen whether these procedures
will be incorporated into current clinical practice.
Operative laparoscopy is also useful in the management
of patients with malignancies of the uterine corpus. In
1988, endometrial cancer became a surgically staged ma-
lignancy according to FIGO. The importance ofpelvic and
paraaortic lymph node status documented by a large
Gynecologic Oncology Group (GOG) study was instru-
mental in motivating the change to surgical staging (15).
In 1992, Childers and Surwit (16) reported the use of a
combined laparoscopic and vaginal approach in the man-
agement oftwo cases of stage adenocarcinoma ofthe en-
dometrium. The lymph node dissection, mobilization of
the adnexae, and procurement ofperitoneal cytology were
performed laparoscopically and then the uterus, tubes, and
ovaries were removed vaginally. The subsequent larger se-
ries published by Childers et al. (2) documented that the
approach is feasible and has an acceptable complicationLAPAROSCOPY IN FEMALE CANCERS 187
rate. The main advantage is a shortened hospital stay and
recovery time. A recent abstract presented data on a com-
parisonbetween laparoscopic managementand traditional
management in patients with endometrial cancer (17).
Patients managed with a laparoscopic approach had the
same number oflymph nodes removed, but had less com-
plications, a shorter hospital stay, and quicker recovery
than the laparotomy group.
In addition to surgical staging in the primary manage-
ment ofendometrial carcinoma patients, the technique can
be utilized in patients with incomplete staging of disease
at their primary surgery. Childers et al. (18) reported on
13 ofthese patients with presumed stage I disease referred
after hysterectomy. Laparoscopic lymphadenectomy was
completed in all patients and residual disease was noted
in three. Laparoscopic restaging is an alternative for pa-
tients referred after incomplete staging ofa variety ofma-
lignancies including uterine sarcomas, epithelial ovarian
carcinomas, sex cord stromal ovarian tumors, and germ
cell tumors of the ovary.
The use of laparoscopy or peritoneoscopy in the man-
agement of epithelial ovarian cancer was first described
in 1973 by Bagley et al. (19). The laparoscope was used
to evaluate patients before and after a chemotherapy pro-
tocol. This initial report highlighted the ability of the la-
paroscope to visualize subdiaphragmatic metastasis likely
to be undetected by conventional laparotomy. Subsequent
studies confirmed that laparoscopy can be used for dis-
ease assessment or "second-look" surgery (20,21).
However, in 1981, Ozols et al. (21) reported that in pa-
tients with a negative second look laparoscopy, immedi-
ate laparotomy revealed residual disease in 55%. Many
gynecologic oncologists concluded that a laparotomy was
required in all cases to confirm the absence of disease.
These results were reported before modern advances in la-
paroscopic surgery, and many laparoscopic surgeons now
believe that second-look procedures can be carded out
with the same false-negative rate as laparotomy. Current
techniques of adhesiolysis and lymphadenectomy con-
tribute to disease reassessment surgery in these patients.
Childers et al. (22) recently reported on 44 laparoscopic
second-look procedures with complication rates similar to
surgery via laparotomy. Similarly, the accuracy in detect-
ing disease (56%)compared favorably with laparotomy.
As mentioned above, another group of patients with
ovarian malignancies that have benefited from laparo-
scopic advances are those patients referred after incom-
plete staging. Patients who have undergone a total
abdominal hysterectomy and bilateral salpingo-oophorec-
tomy without lymphadenectomy can have a laparoscopic
pelvic and paraaortic lymphadenectomy performed. This
is particularly important for early-stage disease, for which
asmany as22% ofstage I malignancies are upstagedbased
on lymph node involvement.
Quedeu et al. (23) performed laparoscopic restaging on
nine patients with apparent early-stage carcinoma of the
ovary or fallopian tube, but with incomplete staging dur-
ing a previous surgical procedure. The authors were able
to complete staging in all nine patients including in-
frarenal, paraaortic lymphnode dissections. They reported
no major complications related to the procedure.
Alternatively, patients can be treated with chemotherapy,
and then a second-look laparoscopy procedure with lym-
phadenectomy canbe performed forreassessmentand sur-
gical staging.
It is clear that laparoscopic approaches to the manage-
ment of gynecologic malignancies are feasible and pro-
vide exciting alternatives. However, the safetyandefficacy
of operative laparoscopy compared to laparotomy in this
setting has not been carefully studied. Potential advan-
tages include shorter operative time for some procedures,
shorterrecovery times, and less adhesion formation. These
new surgical techniques need tobe evaluated critically and
compared to more traditional approaches. Currently, the
GOG, a multicentercooperative group, is conducting stud-
ies to evaluate the use ofoperative laparoscopy in the man-
agement of cervical, endometrial, and ovarian cancer
patients. Multicenter prospective clinical trials like these
are necessary to further define the role of laparoscopy in
gynecologic oncology.
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